1.Survival after surgery for acute type A aortic dissection in octogenarians.
Antonio FIORE ; Javier Rodriguez LEGA ; Joscha BUECH ; Giovanni MARISCALCO ; Andrea PERROTTI ; Konrad WISNIEWSKI ; Angel G PINTO ; Till DEMAL ; Jan ROCEK ; Petr KACER ; Giuseppe GATTI ; Igor VENDRAMIN ; Mauro RINALDI ; Eduard QUINTANA ; Dario Di PERNA ; Francesco NAPPI ; Mark FIELD ; Amer HARKY ; Matteo PETTINARI ; Angelo M DELL'AQUILA ; Francesco ONORATI ; Mikko JORMALAINEN ; Tatu JUVONEN ; Timo MÄKIKALLIO ; Caroline RADNER ; Sven PETERSS ; Vito D'ANDREA ; Fausto BIANCARI
Journal of Geriatric Cardiology 2024;21(11):1015-1025
OBJECTIVE:
To evaluate the benefits of surgical repair acute type A aortic dissection (ATAAD) on survival of octogenarians.
METHODS:
Patients who underwent surgery for acute ATAAD from the multicenter European Registry of Type A Aortic Dissection (ERTAAD) were the subjects of the present analysis.
RESULTS:
326 (8.4%) patients were aged ≥ 80 years. Among 280 propensity score matched pairs, in-hospital mortality was 30.0% in patients aged ≥ 80 years and 20.0% in younger patients (P = 0.006), while 10-year mortality were 93.2% and 48.0%, respectively (P < 0.001). The hazard of mortality was higher among octogenarians up to two years after surgery, but it became comparable to that of younger patients up to 5 years. Among patients who survived 3 months after surgery, 10-year relative survival was 0.77 in patients aged < 80 years, and 0.46 in patients aged ≥ 80 years. Relative survival of octogenarians decreased markedly 5 years after surgery. Age ≥ 85 years, glomerular filtration rate, preoperative invasive ventilation, preoperative mesenteric mal-perfusion and aortic root replacement were independent predictors of in-hospital mortality among octogenarians (AUC = 0.792; E:O ratio = 0.991; CITL = 0.016; slope = 1.096). An additive score was developed. A risk score ≤ 1 was observed in 68.4% of patients, and their in-hospital mortality was 20.9%.
CONCLUSIONS
Provided a thoughtful patient selection, surgery may provide a survival benefit in patients aged ≥ 80 years with ATAAD that, when compared to younger patients and the general population, may last up to 5 years after the procedure. These findings have significant epidemiologic and clinical relevance because of the increasing longevity of the population of the Western countries.
2.Minimally invasive valve surgery: pushing boundaries over the eighty.
Cristina BARBERO ; Dario BRENNA ; Antonio SALSANO ; Marco POCAR ; Erik Cura STURA ; Claudia CALIA ; Viviana SEBASTIANO ; Mauro RINALDI ; Davide RICCI
Journal of Geriatric Cardiology 2023;20(4):276-283
BACKGROUND:
Mean age of patients with valves diseases is significantly increasing, and, in the near future, cardiac surgeons will have to deal with a considerable number of patients aged more than 80 years. The remarkable results gained by the minimally invasive approach have encouraged its application in more complex and fragile patients, such as older people. This study aimed to identify the rate of early mortality and major complications, and independent predictors for mid-term mortality in octogenarians undergoing minimally invasive valve surgery.
METHODS:
Octogenarian patients undergoing right mini-thoracotomy mitral and/or tricuspid valve surgery between 2006 and 2020 were included. Primary endpoint was to identify independent predictors for mid-term mortality, and secondary endpoints were operative morality, stroke, independent predictors for early composite outcome, and quality of life at follow-up.
RESULTS:
Analysis was performed on 130 patients. Stroke occurred in one patient (0.8%), while operative mortality was 6% (eight patients). One-year and five-year survival were 86% and 64%, respectively. Logistic regression identified age and creatinine level as independent predictors of mid-term mortality, survival analysis showed that age ≥ 84 years and creatinine level ≥ 1.22 mg/dL were the cut-off points for worst prognosis. Female gender and hypertension were found to be independent predictors of early composite outcome.
CONCLUSIONS
Results of the present study show that age alone should not be considered a contraindication for minimally invasive valve surgery. Identifying patients who are most likely to have survival and functional benefits after surgery is decisive to achieve optimal health outcomes and prevent futile procedures.

Result Analysis
Print
Save
E-mail